Organic Myco O2, Mushrooms for Life, 60s

This Organic Myco O2 mushroom supplement is based on Traditional Chinese Medicine. It embrace the principle for enhancing the ‘vital breath’, combining these two revered medicinal mushrooms. Reishi is known as the ‘Mushroom of Immortality’. The powerful compounds are extracted by hot water methods to capture the the full essence of the mushrooms. Also known as the ‘Emperors mushroom’, Cordyceps is considered in Chines medicine as the mushroom of  vitality and performance. It contains a unique compound called cordycepin and demonstrates high antioxidant activity.

Organic Myco O2 Ingredients: Organic reishi (Ganoderma lucidum) fruiting body extract powder*. Organic cordyceps (Cordyceps sinensis) biomass powder*, vegetable cellulose capsule (hydroxypropyl methylcellulose).

Study:

This is a study on how Reishi decreased colitis and tumorigenesis, manifested by significantly reduced disease activity index score, and total number and size of tumours. From that study: “This study investigated the effects of water-soluble polysaccharide extracted from the sporoderm-removed spores of Ganoderma lucidum (GLP) against AOM/DSS-induced inflammation, tumorigenesis, and gut microbiota modification, which has never been reported before. Our data revealed that GLP (200 and 300 mg/kg) decreased AOM/DSS-induced colitis and tumorigenesis, manifested by significantly reduced disease activity index score, and total number and size of tumors.

Furthermore, GLP ameliorated AOM/DSS-induced microbiota dysbiosis, increased short-chain fatty acid production, and alleviated endotoxemia by inhibiting TLR4/MyD88/NF-κB signaling. Besides, GLP profoundly improved gut barrier function as evidenced by increased numbers of goblet cells, MUC2 secretion, and tight junction protein expressions. GLP treatment inhibited macrophage infiltration and downregulated IL-1β, iNOS, and COX-2 expressions. Additionally, GLP inhibited lipopolysaccharides (LPS)-induced inflammation markers and MAPK (JNK and ERK) activation in macrophage RAW264.7, intestinal HT-29, and NCM460 cells. In conclusion, these results indicate that GLP is a promising prebiotic for the treatment of colorectal cancer.”